Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
FL 0.405 −1.2% SSRM 35.52 −2.3% CD 0.230 +0.0% GEN 0.070 +0.0% ALS 54.96 −4.3% WGX 4.23 −4.5% LIFT 2.93 −7.0% NTR 95.01 +0.8% ICON 0.045 +0.0% LMG 0.450 +0.0% NZP 0.045 −10.0% RJX 0.030 +0.0% PRU 4.54 −2.2% MOO 0.720 +0.0% BSX 0.810 −14.7% SLI 2.98 −3.2% FL 0.405 −1.2% SSRM 35.52 −2.3% CD 0.230 +0.0% GEN 0.070 +0.0% ALS 54.96 −4.3% WGX 4.23 −4.5% LIFT 2.93 −7.0% NTR 95.01 +0.8% ICON 0.045 +0.0% LMG 0.450 +0.0% NZP 0.045 −10.0% RJX 0.030 +0.0% PRU 4.54 −2.2% MOO 0.720 +0.0% BSX 0.810 −14.7% SLI 2.98 −3.2%
Regulatory

TempraMed Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement

By The Northwire Desk — AI Analysis Nov 18, 2025 · 07:01 VIVI · 0.78 TempraMed Technologies Ltd.
VIVI · Price

Executive Summary

  • TempraMed Technologies Ltd. announced that its common shares are now listed and trading on the Frankfurt Stock Exchange under ticker “9DY,” expanding its European investor reach.
  • The company entered into a three‑month marketing services agreement with bullVestor Medien GmbH, paying a total fee of €130,000 (≈ CAD $210,000) in two installments to boost visibility among European investors.

Key Details

  • Frankfurt Stock Exchange Listing
  • Shares now trade on the Frankfurt Stock Exchange (FSE) under symbol “9DY.”

  • Listing intended to increase trading liquidity and broaden engagement with institutional and retail investors across Europe.

  • Marketing Services Agreement with bullVestor

  • Service period: 3 months, commencing 18 Nov 2025.
  • Scope of services: content creation, ad groups, display ads, keyword optimization, project management, media distribution.
  • Total fee: €130,000 (≈ CAD $210,000).
    • First installment: €75,000 (≈ CAD $120,000) payable within 7 days of agreement date.
    • Second installment: €55,000 (≈ CAD $90,000) payable within 30 days of agreement date.

  • bullVestor and its principals do not own any TempraMed securities at the time of the agreement.

  • Quotes

  • “Listing on the Frankfurt Stock Exchange represents a significant milestone for TempraMed as we expand our presence in the European capital markets,” said Ron Nagar, CEO.

  • “We are excited to partner with bullVestor… to enhance our engagement with the investment community,” added Ron Nagar.

  • Contact Information

  • Investor Relations: Julia Becker, Vice President, Capital Markets – +1 (604) 785‑0850, [email protected]

  • Marketing Services Contact: Helmut Pollinger, bullVestor Medien GmbH – +43 7435 54077‑0, [email protected]

  • Forward‑Looking Statements

  • The release contains forward‑looking statements regarding expected benefits of the FSE listing and marketing activities.

Notable Quotes

“Listing on the Frankfurt Stock Exchange represents a significant milestone for TempraMed as we expand our presence in the European capital markets,” – Ron Nagar, CEO
“We are excited to partner with bullVestor… to enhance our engagement with the investment community,” – Ron Nagar, CEO

Read the original news release →

More from TempraMed Technologies Ltd.

Jun 30, 2026 · 03:06

TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels

M&A / Property Jun 26, 2026 · 16:11

Pioneering passive thermal protection for temperature-sensitive injectables amid aggressive global distribution expansion.

M&A / Property Jun 04, 2026 · 07:01

TempraMed Signs Agreement for Exclusive Distribution Partnership in Brazil, One of the Largest Diabetes and Biologics Markets Globally

Other May 22, 2026 · 11:58

TempraMed Technologies Ltd.

Other May 14, 2026 · 03:01

Indian patent adds IP depth but revenue-sharing financing signals cash crunch

Financings Apr 07, 2026 · 07:01

Brazilian patent bolsters TempraMed’s IP moat ahead of VIVI Box launch.

M&A / Property